AstraZeneca shares in tentative rebound

feature image
AstraZeneca, the pharmaceutical group, reported that its COVID-19 vaccine has been approved for emergency supply in the U.K. and vaccinations may begin early in the New Year.

From a chartist’s point of view, the stock price is holding above a key support at 7121p and is rebounding from the lower end of a bearish channel. The daily RSI has landed on a key support around 30% and is reversing up. A technical rebound could be on the cards. A break above 7880p (upper channel boundary) would validate a bullish signal with 8140p and 8848p as targets. Alternatively, a break below 7121p would negate the bullish view and would call for a slump towards 6315p and 5871p (congestion zone).

Source: GAIN Capital, TradingView


Related tags: equities

Open an account in minutes

Experience award-winning platforms with fast and secure execution.

Live Trading Webinars

Our interactive webinars, led by our industry experts, come highly recommended and can help provide your trading with the edge it needs.
Economic Calendar